Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant for Alzheimer Disease Prevention
NCT07213349Phase 2Recruiting
- Sponsor
- Douglas Mental Health University Institute
- Start
- Oct 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daridorexant in Alzheimer's disease (AD), sponsored by Douglas Mental Health University Institute. Started Oct 2025; status: recruiting.
02
Drugs
daridorexant
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07213349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07213349.